Anuh Pharma Faces Significant Selling Pressure with 27.42% Year-to-Date Loss Amid Poor Performance

Anuh Pharma Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of losses, as the company has experienced a decline of 0.29% in its stock price, compared to a slight decrease of 0.12% in the Sensex. Over the past week, Anuh Pharma has seen a more pronounced drop of 4.55%, while the Sensex has gained 1.39%. The stock's performance over the last three months has been particularly concerning, with a decline of 7.20%, contrasting sharply with the Sensex's increase of 4.69%. Year-to-date, Anuh Pharma has plummeted by 27.42%, while the Sensex has risen by 7.98%. This trend is further highlighted by the stock's performance over the past five and ten years, where it has remained stagnant at 0.00%, while the Sensex has surged by 93.35% and 229.46%, respectively. Contributing factors to the selling pressure may include the stock's underperformance relative to its sector and its trading below key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This trend reversal follows two days of gains, indicating a shift in market sentiment.